| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QSI | Class A Common Stock | Sale | -$70.9K | -12.1K | -5.5% | $5.86 | 208K | Jan 10, 2022 | Direct | F1, F2, F3 |
| transaction | QSI | Class A Common Stock | Sale | -$3.41K | -542 | -0.26% | $6.28 | 208K | Jan 11, 2022 | Direct | F1, F3, F4 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on February 17, 2021 pursuant to a "sell to cover" provision included in the RSU Agreement. |
| F2 | Represents the weighted average sales price per share. The shares sold at prices ranging from $5.71 to $6.41 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| F3 | Includes 127,760 RSUs. Each RSU represents the right to receive one share of common stock upon vesting. 42,586 RSUs vested on January 7, 2022, with 127,760 RSUs vesting in 12 equal quarterly installments thereafter, subject to Dr. LaPointe's continued service through the applicable vesting date. |
| F4 | Represents the weighted average sales price per share. The shares sold at prices ranging from $6.25 to $6.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |